Audio recording of Investors/analysts call with Management

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

J.B. Chemicals & Pharmaceuticals has informed the stock exchanges that the audio recording of its Q4 FY25 earnings conference call held on May 15, 2025 is now available on the company's website. The call covered results and developments for the quarter ended March 31, 2025. This is a routine compliance filing under SEBI's Listing Regulations. Investors can listen to the recording via the link provided in the filing.

Likely market impact

This is a regulatory disclosure with no direct stock price impact. Investors seeking management commentary on FY25 performance and future outlook should review the actual call audio for any forward-looking guidance.